EZH2 and hepatocellular carcinoma: In order to evaluate our hypothesis, we transfected oe‐EZH2 in P53 overexpressing HCC‐LM3 and Huh‐7 cells to ascertain whether EZH2 could reverse the anti‐tumour effect of P53 overexpression.